SKI Market

A+| A| A-|

Indian Indices

Sensex

73,319.55 185.23
( 0.25%)

Global Indices

Nasdaq

46,526.80 -59.95
(-0.13%)

Dow Jones

6,603.92 7.60
(0.12%)

Hang Seng

53,162.49 699.22
(1.33%)

Nikkei 225

10,436.29 71.50
(0.69%)

Forex

USD-INR

93.17 -0.69
(-0.73%)

EUR-INR

107.97 0.00
(0.00%)

GBP-INR

123.80 -0.23
(-0.19%)

JPY-INR

0.59 0.00
(-0.32%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

SPML Infra Ltd

Industry : Construction

BSE Code

ISIN Demat

Book Value()

500402

INE937A01023

123.7452257

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SPMLINFRA

22.66

1352.18

EPS(TTM)

Face Value()

Div & Yield %

7.57

Back

Bal Pharma consolidated net profit declines 31.73% in the September 2025 quarter

Nov 13,2025

Net profit of Bal Pharma declined 31.73% to Rs 0.71 crore in the quarter ended September 2025 as against Rs 1.04 crore during the previous quarter ended September 2024. Sales rose 0.45% to Rs 74.02 crore in the quarter ended September 2025 as against Rs 73.69 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	74.02	73.69	0
OPM %	7.74	10.44	-
PBDT	2.99	3.84	-22
PBT	0.72	1.36	-47
NP	0.71	1.04	-32

73,319.55 185.23 ( 0.25%)

46,526.80 -59.95 (-0.13%)

6,603.92 7.60 (0.12%)

53,162.49 699.22 (1.33%)

10,436.29 71.50 (0.69%)

93.17 -0.69 (-0.73%)

107.97 0.00 (0.00%)

123.80 -0.23 (-0.19%)

0.59 0.00 (-0.32%)